Welcome to our dedicated page for Oppenheimer Hld news (Ticker: OPY), a resource for investors and traders seeking the latest updates and insights on Oppenheimer Hld stock.
Oppenheimer Holdings Inc. (NYSE: OPY) is a middle market investment bank and full service broker-dealer active in the investment banking and securities industry. Through its subsidiaries, including Oppenheimer & Co. Inc., the firm reports news on retail securities brokerage, institutional sales and trading, investment banking, equity and fixed income research, market-making, trust services, and investment advisory and asset management services.
The OPY news flow frequently includes quarterly earnings releases detailing segment results for Wealth Management and Capital Markets, trends in assets under management, and commentary from management on market conditions. Investors can follow updates on advisory and underwriting activity, equities and fixed income trading volumes, and changes in revenue components such as commissions, advisory fees, and bank deposit sweep income.
Company announcements also highlight capital actions and corporate events, such as the declaration of quarterly and special cash dividends on Class A non-voting and Class B voting common stock, as reported in press releases and related Form 8-K filings. In addition, Oppenheimer regularly reports on senior hires and team expansions across its platform, including appointments in Healthcare Equity Capital Markets, biotech research, public finance investment banking, cash equity sales and trading, and regional wealth management leadership.
Other OPY news items describe the evolution of the firm’s Custody and Prime Services (CAPS) platform and the expansion of its global credit and high yield and distressed businesses in the U.S., Europe, and Asia. For readers tracking OPY, this news page offers a centralized view of earnings updates, strategic hires, platform developments, and capital-related announcements drawn from company press releases and disclosures.
On June 15, 2021, Oppenheimer announced significant expansion of its Financial Institutions investment banking group with the hiring of veteran bankers Cliff Booth and JD Nelson. Booth takes the role of Managing Director and Head of Specialty Finance Investment Banking, while Nelson will serve as Managing Director in Specialty Finance. Additionally, Mitchel Penn joins as Managing Director for Equity Research, enhancing the firm's focus on business development corporations. This strategic growth aims to support Oppenheimer's impressive investment banking performance, which saw revenues surge to $222 million in 2020, up 70% from 2019.
Oppenheimer Holdings reported a net income of $38.7 million or $3.07 per share for Q1 2021, soaring 400% compared to $7.8 million or $0.61 per share in Q1 2020. Revenue reached $373.3 million, a 59% increase from $234.8 million in the prior year. The growth was driven by strong equity underwriting, particularly in healthcare and technology sectors, and a flourishing M&A advisory business. However, increased compensation costs of $11.6 million impacted earnings. The company also announced a quarterly dividend of $0.12 per share.
On March 23, 2021, Oppenheimer announced key additions to its Healthcare Investment Banking team, enhancing its capabilities in M&A and capital raising. Jonathan Fassberg joins as Vice Chairman, with his extensive experience in biotech and life sciences. Brian Korb and Don Ritucci assume Managing Director roles, with Ritucci heading Healthcare M&A. These strategic hires aim to strengthen Oppenheimer's position in the fast-growing healthcare sector and offer comprehensive advisory services to clients.
Oppenheimer successfully concluded its 31st Annual Healthcare Conference held virtually from March 16-18, 2021. The event showcased discussions from over 240 healthcare companies, focusing on key industry trends and investment opportunities. Oppenheimer's Healthcare Investment Banking team reported a 73% increase in bookrun deal volume and a 50% rise in average deal size in the past year. The conference featured notable keynotes, including Dr. Scott Gottlieb discussing the COVID-19 'endgame,' emphasizing the industry's crucial role in economic recovery.
Oppenheimer Holdings reported a significant rise in Q4 2020, with net income of $81.9 million ($6.56 EPS), up from $25.4 million ($1.99 EPS) in Q4 2019. Q4 revenue increased by 42.9% to $422.9 million, while FY 2020 net income rose to $123.0 million ($9.73 EPS), compared to $53.0 million in FY 2019. Revenue for FY 2020 was $1.2 billion, a 16.0% increase year-over-year. Record performance was noted in both the Asset Management and Capital Markets segments, attributed to high volatility and strong equity markets.
Oppenheimer & Co. Inc. recently announced the appointment of Bob McCabe as Branch Manager and Senior Director of Investments at its Palm Beach Gardens office. With over 35 years of financial services experience, McCabe aims to enhance asset management and profitability. This addition strengthens the leadership team overseeing 41 advisors managing nearly $3 billion in assets. McCabe's previous roles included Managing Director at Fieldpoint Private and key positions at Morgan Stanley and Smith Barney. His extensive background positions him well to drive future growth at Oppenheimer.
Oppenheimer Holdings Inc. (OPY) has declared a special cash dividend of $1.00 per share on its Class A non-voting and Class B voting common stock. The dividend, totaling approximately $12.4 million, will be paid on December 30, 2020, to shareholders recorded by the close of business on December 23, 2020. This announcement reflects the company's improved financial position and aims to reward shareholder loyalty. Chairman Albert G. Lowenthal expressed optimism about future growth.
Oppenheimer & Co. Inc. has appointed Guillaume Petitgas as Managing Director in its Debt Capital Markets Group, enhancing its leadership team. Based in London, Petitgas brings over 15 years of experience in Emerging Markets debt issuance, having previously held senior roles at HSBC and Merrill Lynch. He will focus on DCM transactions primarily across CEEMEA. The firm aims to strengthen its presence in Emerging EMEA and frontier markets with this strategic buildout. The announcement reflects Oppenheimer's commitment to enhancing its global DCM capabilities.
Oppenheimer Holdings Inc. (OPY) has extended its exchange offer for its 5.50% Senior Secured Notes due 2025 by an additional five days, now set to expire on November 23, 2020. The company aims to exchange $125 million of these notes for newly registered notes under the Securities Act. As of November 18, 2020, approximately $124.55 million, or 99.64%, of the outstanding notes have been tendered. All other terms remain unchanged. The Bank of New York Mellon Trust Company, N.A. will serve as the exchange agent.
Oppenheimer & Co. Inc. has appointed James Murray as Managing Director in its Global Consumer Investment Banking Group, based in London. With over 20 years of experience, Murray will enhance Oppenheimer's capabilities in the UK and Europe, focusing on strategic advice for consumer clients and M&A activities. This move is part of Oppenheimer's commitment to expanding its Investment Banking services in Europe. Murray's prior experience includes a role as Partner and Head of Consumer M&A at KPMG, managing over $50 billion in transactions.